HomeProductsBioactive CompoundsProtein Kinase TargetsIGF-1RNVP-AEW541
Chemical structure of CAS 475489-16-8

NVP-AEW541

CAS No.475489-16-8
MDL No.MFCD22741515
MFC27H29N5O
MW439.60
InChI KeyAECDBHGVIIRMOI-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.475489-16-8
Product NameNVP-AEW541
Heavy Atom Count33Rotatable Bond Count7
Atom Stereo Count0Bond Stereo Count0
HBA6HBD1
TPSA69.200 ŲCharge0
Exact Mass439.23721Complexity1258.25
pKa7.130XLogP4.916

Related Articles

Studies related to this compound and its mechanism of action

IGF-1 prevents simvastatin-induced myotoxicity in C2C12 myotubes.

Archives of toxicology • Vol. 91, Issue 5 • 2017
PMID: 27734117DOI: 10.1007/s00204-016-1871-z

Insulin-like growth factor-1 boosts the developing process of condylar hyperplasia by stimulating chondrocytes proliferation.

Osteoarthritis and cartilage • Vol. 20, Issue 4 • 2012
PMID: 22281262DOI: 10.1016/j.joca.2011.12.013

Co-administration of NVP-AEW541 and dasatinib induces mitochondrial-mediated apoptosis through Bax activation in malignant human glioma cell lines.

International journal of oncology • Vol. 37, Issue 3 • 2010
PMID: 20664932DOI: 10.3892/ijo_00000712

Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.

Cancer research • Vol. 69, Issue 10 • 2009
PMID: 19435893PMC: PMC2724871DOI: 10.1158/0008-5472.CAN-09-0042

Documentation